These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3984680)

  • 1. Antioxidant treatment in Spielmeyer-Sjögren's disease.
    Santavuori P; Westermarck T; Rapola J; Pohja P; Moren R; Lappi M; Vuonnala U
    Acta Neurol Scand; 1985 Feb; 71(2):136-45. PubMed ID: 3984680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease.
    Santavuori P; Heiskala H; Westermarck T; Sainio K; Moren R
    Am J Med Genet Suppl; 1988; 5():265-74. PubMed ID: 3146324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. English setter model and juvenile ceroid-lipofuscinosis in man.
    Koppang N
    Am J Med Genet; 1992 Feb; 42(4):599-604. PubMed ID: 1609842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium treatment in neuronal ceroid-lipofuscinosis.
    Naidu S; Maumanee I; Olson J; Borel J; Moser H
    Am J Med Genet Suppl; 1988; 5():283-9. PubMed ID: 3146327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of caries and periodontal disease in selenium-treated patients with Spielmeyer-Sjögren's disease.
    Saxén L; Viljanen T; Westermarck T
    Scand J Dent Res; 1983 Oct; 91(5):356-9. PubMed ID: 6579618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type.
    Santavuori P; Moren R
    Neuropadiatrie; 1977 Nov; 8(4):333-44. PubMed ID: 579434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

  • 9. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 10. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant micronutrients for lung disease in cystic fibrosis.
    Shamseer L; Adams D; Brown N; Johnson JA; Vohra S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007020. PubMed ID: 21154377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation.
    Jensen GE; Clausen J
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():450-3. PubMed ID: 3776606
    [No Abstract]   [Full Text] [Related]  

  • 13. Report bodes ill for antioxidant supplementation.
    Larkin M
    Lancet; 2000 Apr; 355(9213):1433. PubMed ID: 10791533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antioxidative therapy in ceroid lipofuscinosis].
    Rotteveel JJ; Mullaart RA
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):181-6. PubMed ID: 2815055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical courses in patients with juvenile neuronal ceroid lipofuscinosis receiving antioxidant treatment and those without antioxidant treatment.
    Santavuori P; Heiskala H; Autti T; Johansson E; Westermarck T
    Adv Exp Med Biol; 1989; 266():273-82. PubMed ID: 2486154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of selenium, methionine and antioxidants against encephalomalacia of chicks induced by dilauryl succinate.
    Yoshida M; Hoshi H
    J Nutr; 1977 Jan; 107(1):35-41. PubMed ID: 833678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of antioxidants in experimental poisoning].
    Setko NP
    Gig Sanit; 1986 Feb; (2):16-8. PubMed ID: 3957046
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause.
    Gann PH
    JAMA; 2009 Jan; 301(1):102-3. PubMed ID: 19066369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Seasonal effectiveness of antioxidants in tetracycline lesions of the liver].
    Vysotskiĭ IB
    Antibiotiki; 1984 Aug; 29(8):590-4. PubMed ID: 6486755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antioxidant effectiveness in isoniazid-induced lesions of the liver].
    Skakun NP; Shman'ko VV
    Farmakol Toksikol; 1986; 49(4):86-9. PubMed ID: 3758339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.